A detailed history of Capital Advisors Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital Advisors Inc holds 10,819 shares of EW stock, worth $809,369. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,819
Previous 10,834 0.14%
Holding current value
$809,369
Previous $1 Million 28.7%
% of portfolio
0.01%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$59.7 - $93.78 $895 - $1,406
-15 Reduced 0.14%
10,819 $713,000
Q2 2024

Jul 31, 2024

SELL
$84.3 - $94.31 $6,491 - $7,261
-77 Reduced 0.71%
10,834 $1 Million
Q1 2024

Apr 29, 2024

BUY
$72.54 - $95.56 $3,046 - $4,013
42 Added 0.39%
10,911 $1.04 Million
Q4 2023

Jan 29, 2024

SELL
$61.71 - $77.76 $9,565 - $12,052
-155 Reduced 1.41%
10,869 $828,000
Q2 2023

Jul 18, 2023

SELL
$81.41 - $94.33 $4,966 - $5,754
-61 Reduced 0.55%
11,024 $1.04 Million
Q1 2023

Apr 19, 2023

BUY
$74.26 - $84.51 $4,529 - $5,155
61 Added 0.55%
11,085 $917,000
Q4 2022

Jan 17, 2023

BUY
$68.3 - $87.44 $10,586 - $13,553
155 Added 1.43%
11,024 $0
Q2 2022

Jul 15, 2022

SELL
$86.5 - $128.27 $110,028 - $163,159
-1,272 Reduced 10.48%
10,869 $1.03 Million
Q3 2021

Oct 25, 2021

BUY
$102.91 - $122.75 $502,921 - $599,879
4,887 Added 67.37%
12,141 $1.37 Million
Q4 2020

Feb 08, 2021

SELL
$71.69 - $91.23 $3,871 - $4,926
-54 Reduced 0.74%
7,254 $661,000
Q3 2020

Nov 02, 2020

BUY
$67.19 - $87.44 $164,884 - $214,577
2,454 Added 50.56%
7,308 $583,000
Q2 2020

Aug 07, 2020

BUY
$57.54 - $76.95 $186,199 - $249,010
3,236 Added 200.0%
4,854 $376,000
Q1 2020

May 21, 2020

SELL
$52.41 - $81.0 $314 - $486
-6 Reduced 0.37%
1,618 $101,000
Q4 2019

Feb 04, 2020

SELL
$71.7 - $82.09 $2,796 - $3,201
-39 Reduced 2.35%
1,624 $126,000
Q2 2019

Aug 07, 2019

BUY
$55.74 - $64.41 $92,695 - $107,113
1,663 New
1,663 $0

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Capital Advisors Inc Portfolio

Follow Capital Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.